Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-27 @ 4:08 AM
Study NCT ID:
NCT05677893
Status:
COMPLETED
Last Update Posted:
2025-03-30
First Post:
2022-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants
Sponsor:
Oneness Biotech Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-30
Completion Date Type:
ACTUAL
First Submit Date:
2022-11-04
First Submit QC Date:
None
Study First Post Date:
2023-01-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-03-07
Results First Submit QC Date:
None
Results First Post Date:
2025-03-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-28
Last Update Post Date:
2025-03-30
Last Update Post Date Type:
ACTUAL